Shareholders to Vote on Massive Dilution, Reverse Stock Split, and Chairman's Equity Exchange

summarizeSummary

Avalon GloboCare Corp. has filed a definitive proxy statement for a special meeting to approve significant dilutive financing transactions, including conversions of notes and preferred stock, a large equity exchange with the Chairman, and a reverse stock split to maintain Nasdaq listing.

check_boxKey Events · Corporate Governance and Compliance · ALBT

• Shareholder Meeting Scheduled

  A special meeting of stockholders is scheduled for March 30, 2026, to vote on seven key proposals.

• Approval Sought for Significant Dilution

  Shareholders will vote on approving the issuance of shares from the conversion of July 2025 convertible notes, December 2025 bridge notes (with punitive 50% VWAP conversion), and Series C Convertible Preferred Stock, all exceeding Nasdaq's 19.99% rule. These conversions could add over 2.7 million shares.

• Chairman's Equity Exchange Proposed

  A proposal seeks approval for an exchange agreement with Chairman Wenzhao Lu, where 5,000 shares of Series D Preferred Stock would be exchanged for 2,074,689 shares of common stock, subject to Nasdaq listing rules for equity compensation and dilution.

• Reverse Stock Split Authority Requested

  The board is seeking discretionary authority to effect a reverse stock split at a ratio between 1-for-2 and 1-for-25 to increase the common stock's bid price and maintain Nasdaq listing compliance.

auto_awesomeAnalysis · ALBT · Technology

This definitive proxy statement outlines multiple critical proposals for a special shareholder meeting on March 30, 2026, following a preliminary proxy filing on February 18, 2026. The proposals collectively seek approval for potentially massive dilution, including the conversion of various convertible notes and preferred stock, and a significant equity exchange with the Chairman. The most impactful proposals include the conversion of Series C Preferred Stock (potentially 1.58 million shares), an exchange of Series D Preferred Stock for 2.07 million common shares with Chairman Wenzhao Lu, and the conversion of a December 2025 bridge note with punitive 50% VWAP conversion terms. Cumulatively, these proposals could lead to the issuance of over 5.2 million new shares, representing more than 84% dilution to current outstanding shares. Furthermore, the company is seeking authorization for a reverse stock split at a ratio of 1-for-2 to 1-for-25, primarily to maintain its Nasdaq listing. This indicates severe financial distress and a high risk of delisting. The sheer scale of potential dilution, coupled with the necessity of a reverse split, presents a highly negative outlook for existing shareholders.